The Effect of Picricum Acidum and Phosphoricum Acidum Homaccord on Perceived Levels of Anxiety in University Students
Launched by UNIVERSITY OF JOHANNESBURG · Aug 4, 2014
Trial Information
Current as of June 30, 2025
Completed
Keywords
ClinConnect Summary
This study will be a randomized, double-blind, placebo-controlled study, conducted over a two-week period at the University of Johannesburg (UJ) Health Clinic, Doornfontein Campus. Thirty university students, aged between 18 and 45 years, will be recruited into the study by means of advertisements placed on the campus with relevant permission given. Participants will attend an initial consultation and will be requested to sign a Participant Information and Consent form, complete the Participant Information Sheet, and a Remedy Symptom Questionnaire to determine inclusion into the study. Part...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Male or female, between the ages of 18 and 45;
- • Registered University students;
- • Participants must experience anxiety symptoms, manifesting six or more of the following criteria: muscle tension, increased perspiration, rapid heartbeat, headaches, stomach aches, agitation, irritability, hostility, fear, extreme sensitivity to rejection or failure, motor restlessness, procrastination, excessive worry, concentration difficulties, attention difficulties and memory problems;
- • Participants must be writing a major examination one week after the study ends;
- • Participants must have six or more of the symptoms relating to Picricum acidum and Phosphoricum acidum (Appendix D); and
- • Participants must have a cell phone and on-line computer access.
- Exclusion Criteria:
- • • Have been diagnosed with: A psychological anxiety disorder, Psychiatric disorders (Bipolar disorder, Depression), Attention Deficit Hyperactivity Disorder and Epilepsy.
- • Are taking any chronic medication for anxiety or mood stabilizing
- • Are pregnant or lactating
About University Of Johannesburg
The University of Johannesburg (UJ) is a leading higher education institution in South Africa, renowned for its commitment to research and innovation across various disciplines, including health sciences. As a clinical trial sponsor, UJ leverages its academic expertise and state-of-the-art facilities to conduct rigorous and ethically sound clinical research. The university fosters collaboration between researchers, healthcare professionals, and industry partners, aiming to advance medical knowledge and improve patient outcomes. UJ is dedicated to upholding the highest standards of scientific integrity and compliance, contributing to the global body of evidence-based medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Johannesburg, Gauteng, South Africa
Patients applied
Trial Officials
Janice Pellow, M.Tech Hom
Study Director
University of Johannesburg
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials